Archana Asundi, MD
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Infectious Diseases

MD, McGill University
BA, Tufts University

Pronouns: she/her/hers



Dr. Archana Asundi is a physician-scientist and infectious disease clinician, who specializes in care of people living with HIV with a specific focus on HIV and Aging. In her role Director of the Infectious Disease Clinical Research Unit (ID-CRU) at Boston Medical Center, she supports and oversees the conduct of a large portfolio of clinical trials and clinical-translational research studies in the Center for Infectious Disease (CID). Her individual research program focuses on investigating cardiometabolic comorbidities and weight gain/obesity among people living with HIV. She also engages in quality improvement and continuing medical education in the area of HIV and aging with several projects ongoing targeted around improvement of health-related quality of life among people aging with HIV.



Pre notification HIV RNA modification and innate immune activation in HIV infection
07/08/2024 - 06/30/2029 (Subcontract PI)
PI: Archana Asundi, MD
Trustees of Boston University, BUMC NIH NIAID

GSK 3515864: A Phase 3b, multicenter, single-arm, open-label study evaluating the efficacy, safety, and tolerability of switching to DTG/3TC single tablet regimen administered once daily from a bictegravir/emtricitabine/tenofovir alafenamide single table
10/23/2023 - 10/23/2028 (PI)
ViiV Healthcare

GS-US-563-6041: A Phase 2 Randomized, Open-Label, Active-Controlled Study Evaluating the Safety and Efficacy of an Oral Weekly Regimen of Islatravir in Combination with Lenacapavir in Virologically Suppressed People with HIV
04/06/2023 - 12/31/2027 (PI)
Gilead Sciences

GS-US-380-6738: A Phase 4 Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Oral B/F/TAF after Discontinuing Injectable CAB + RPV
12/01/2023 - 12/01/2027 (PI)
Gilead Sciences

TH-IBA-CTR-1003 PROMISE-US
10/27/2022 - 10/27/2025 (PI)
THERATECHNOLOGIES U.S., INC.

Special Projects of National Significance - Demonstration/Implementation Sites
08/01/2022 - 07/31/2025 (PI)
Health Resources and Services Administration/DHHS

Gamma delta T cells promote inflammation in aviremic HIV infection and normal aging
08/15/2020 - 05/31/2025 (Subcontract PI)
PI: Archana Asundi, MD
Trustees of Boston University, BUMC NIH NIAID
5R01AG065050-03

Is Integrase Inhibitor Emergent Weight Gain associated with increased Cardiometabolic Risk? A Nationwide Cohort Analysis
01/24/2022 - 02/01/2025 (PI)
Gilead Sciences

Identifying Factors to Improve Dental and Mental Healthcare among People with HIV
09/22/2023 - 09/21/2024 (Subcontract PI)
PI: Archana Asundi, MD
Rhode Island Hospital NIH NIDCR
1R56DE032873-01

Solar GSK213500: A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine administer
01/25/2021 - 01/24/2024 (PI)
GlaxoSmithKline

Showing 10 of 11 results. Show All Results

Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Pihl RMF, Smith-Mahoney EL, Olson A, Yuen RR, Asundi A, Lin N, Belkina AC, Snyder-Cappione JE. Vd1 Effector and Vd2 ?d T-Cell Subsets Shift in Frequency and Are Linked to Plasma Inflammatory Markers During Antiretroviral Therapy-Suppressed HIV Infection. J Infect Dis. 2024 May 15; 229(5):1317-1327.View Related Profiles. PMID: 38390982; PMCID: PMC11095541; DOI: 10.1093/infdis/jiae091;
     
  2. Lilie T, Bouzy J, Asundi A, Taylor J, Roche S, Olson A, Coxen K, Corry H, Jordan H, Clayton K, Lin N, Tsibris A. Opioid use does not limit potent low-dose HIV-1 latency reversal agent boosting. medRxiv. 2023 Jun 03. PMID: 37398278; PMCID: PMC10312897; DOI: 10.1101/2023.05.26.23290576;
     
  3. Asundi A, Olson A, Jiang W, Varshney SP, White LF, Sagar M, Lin NH. Integrase Inhibitor Use Associated with Weight Gain in Women and Incident Diabetes Mellitus. AIDS Res Hum Retroviruses. 2022 03; 38(3):208-215.View Related Profiles. PMID: 34877881; PMCID: PMC8968841; DOI: 10.1089/aid.2021.0091;
     
  4. Asundi A, O'Leary C, Bhadelia N. Global COVID-19 vaccine inequity: The scope, the impact, and the challenges. Cell Host Microbe. 2021 07 14; 29(7):1036-1039.View Related Profiles. PMID: 34265241; PMCID: PMC8279498; DOI: 10.1016/j.chom.2021.06.007;
     
  5. Asundi A, Resnik J, Benedict PA, Shin M, Rani Elwy A, Branch-Elliman W. How Are Emerging Data Translated Into Clinical Practice? A Mixed Methods Investigation of Coronavirus Disease 2019 Institutional Treatment Protocols. Open Forum Infect Dis. 2021 Apr; 8(4):ofab072.View Related Profiles. PMID: 33855102; PMCID: PMC8026152; DOI: 10.1093/ofid/ofab072;
     
  6. Asundi A, Stanislawski M, Mehta P, Mull HJ, Schweizer ML, Barón AE, Ho PM, Gupta K, Branch-Elliman W. Development and Validation of a Semi-Automated Surveillance Algorithm for Cardiac Device Infections: Insights from the VA CART program. Sci Rep. 2020 03 24; 10(1):5276.View Related Profiles. PMID: 32210289; PMCID: PMC7093485; DOI: 10.1038/s41598-020-62083-y;
     
  7. Mull HJ, Stolzmann K, Kalver E, Shin MH, Schweizer ML, Asundi A, Mehta P, Stanislawski M, Branch-Elliman W. Novel methodology to measure pre-procedure antimicrobial prophylaxis: integrating text searches with structured data from the Veterans Health Administration's electronic medical record. BMC Med Inform Decis Mak. 2020 01 30; 20(1):15.View Related Profiles. PMID: 32000780; PMCID: PMC6993312; DOI: 10.1186/s12911-020-1031-5;
     
  8. Asundi A, Bhadelia N. Making Emergency Use of Experimental Vaccines Safer. AMA J Ethics. 2020 01 01; 22(1):E43-49.View Related Profiles. PMID: 31958390
     
  9. Asundi A, Cervantes-Arslanian AM, Lin NH, Barbosa F. Infectious Myelitis. Semin Neurol. 2019 08; 39(4):472-481.View Related Profiles. PMID: 31533188
     
  10. Asundi A, Robles Y, Starr T, Landay A, Kinslow J, Ladner J, White L, Plank RM, Melbourne K, Weisholtz D, Bennett M, Pan H, Stern E, Lin A, Kuritzkes DR, Lin NH. Immunological and Neurometabolite Changes Associated With Switch From Efavirenz to an Integrase Inhibitor. J Acquir Immune Defic Syndr. 2019 08 15; 81(5):585-593.View Related Profiles. PMID: 31045650; PMCID: PMC6625862; DOI: 10.1097/QAI.0000000000002079;
     
Showing 10 of 14 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 14 publications over 8 distinct years, with a maximum of 4 publications in 2019

YearPublications
20111
20181
20194
20203
20212
20221
20231
20241

Note: X.com has changed/limited the ability to embed tweets directly in external sites and we are investigating ways to restore that functionality in BU Profiles. In the meantime we are displaying a link to your x.com profile in the Websites section above.

Flurry of New Research Explores Weight Gain on Integrase Inhibitors Among People Living With HIV

The Body Pro 10/27/2020
Contact for Mentoring:

617.414.5260
Download vCard

Asundi's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (109) concept(s)
_
Media Mentions
_
Co-Authors
See all (12) people
_
Similar People
See all (60) people
_
Same Department
Search Department